Research progress on the association between TMAO and vascular calcification in patients with chronic kidney disease

被引:0
|
作者
Zhang, Yuxin [1 ,2 ,3 ]
Huang, Liangying [1 ,2 ,3 ]
Ou, Santao [1 ,2 ,3 ]
机构
[1] Southwest Med Univ, Affiliated Hosp, Dept Nephrol, Luzhou, Peoples R China
[2] Sichuan Clin Res Ctr Nephropathy, Luzhou, Peoples R China
[3] Metab Vasc Dis Key Lab Sichuan Prov, Luzhou, Peoples R China
关键词
Chronic kidney disease; enteric-borne urinary toxin; TMAO; vascular calcification; TRIMETHYLAMINE-N-OXIDE; GLYCATION END-PRODUCTS; SERUM-LEVELS; L-CARNITINE; NLRP3; INFLAMMASOME; OXIDATIVE STRESS; HEALTH; CONTRIBUTES; MICROBIOME; METABOLISM;
D O I
10.1080/0886022X.2024.2435485
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Vascular calcification (VC) is a common complication in patients with chronic kidney disease (CKD) and a major risk factor for increased cardiovascular mortality in patients with CKD. Its pathology and pathogenesis are complex and have not been fully elucidated. Trimethylamine N-oxide (TMAO) is an enteric-borne uremic toxin that has been found to play a role in the progression of VC. This article mainly reviews the metabolism of TMAO, the relationship between TMAO and VC in CKD patients, and possible treatments for TMAO, aiming to further explore the mechanism of VC occurrence in CKD patients and provide potential diagnostic and treatment strategies.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] The Association of TWEAK with Coronary Artery Calcification in Patients with Chronic Kidney Disease
    Tatlisu, Mustafa Adem
    Atici, Adem
    Ozcan, Fatma Betul
    Celik, Mehmet
    Kirac, Eray
    Baycan, Omer Faruk
    Caliskan, Mustafa
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2022, 119 (03) : 436 - 445
  • [32] Comparing different calcification scores to detect outcomes in chronic kidney disease patients with vascular calcification
    NasrAllah, Mohamed M.
    Nassef, Amr
    Elshaboni, Tarik H.
    Morise, Fadia
    Osman, Noha A.
    El Din, Usama A. Sharaf
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 884 - 889
  • [33] Connections between vascular calcification and progression of chronic kidney disease: Therapeutic alternatives
    Hruska, KA
    Mathew, S
    Davies, MR
    Lund, RJ
    KIDNEY INTERNATIONAL, 2005, 68 : 142 - 151
  • [34] ASSOCIATIONS BETWEEN VASCULAR CALCIFICATION, ARTERIAL STIFFNESS AND BONE MINERAL DENSITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Toussaint, N. D.
    Lau, K. K.
    Polkinghorne, K. R.
    Kerr, P. G.
    NEPHROLOGY, 2007, 12 : A33 - A33
  • [35] Targeting a Silent Disease: Vascular Calcification in Chronic Kidney Disease
    Marreiros, Catarina
    Viegas, Carla
    Simes, Dina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [36] Food to Prevent Vascular Calcification in Chronic Kidney Disease
    Moldovan, Diana
    Rusu, Crina
    Potra, Alina
    Tirinescu, Dacian
    Ticala, Maria
    Kacso, Ina
    NUTRIENTS, 2024, 16 (05)
  • [37] Vascular Calcification in Chronic Kidney Disease: An Update and Perspective
    Ren, Si-Chong
    Mao, Nan
    Yi, Si
    Ma, Xin
    Zou, Jia-Qiong
    Tang, Xiaoqiang
    Fan, Jun Ming
    AGING AND DISEASE, 2022, 13 (03): : 673 - 697
  • [38] A molecular target of vascular calcification in chronic kidney disease
    Atta, Mohamed G.
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (01):
  • [39] Pulmonary Hypertension - Prevalence, Risk Factors, and Its Association with Vascular Calcification in Chronic Kidney Disease and Hemodialysis Patients
    Nithiya, N.
    Indhumathi, Elayaperumal
    Jagadeswaran, Dhakshinamoorty
    Jayaprakash, Varadharajan
    Jayakumar, Matcha
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2020, 31 (02) : 380 - 387
  • [40] Future treatment of vascular calcification in chronic kidney disease
    Cozzolino, Mario
    Maffei Faccioli, Federico
    Cara, Anila
    Boni Brivio, Giulia
    Rivela, Francesca
    Ciceri, Paola
    Magagnoli, Lorenza
    Galassi, Andrea
    Barbuto, Simona
    Speciale, Serena
    Minicucci, Carlo
    Cianciolo, Giuseppe
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2041 - 2057